News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,311 Results
Type
Article (39565)
Company Profile (247)
Press Release (656499)
Section
Business (204104)
Career Advice (2007)
Deals (35415)
Drug Delivery (94)
Drug Development (81020)
Employer Resources (172)
FDA (16156)
Job Trends (14844)
News (345058)
Policy (32500)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (4)
Adcomms (20)
Allergies (80)
Alliances (49374)
ALS (83)
Alzheimer's disease (1356)
Antibody-drug conjugate (ADC) (109)
Approvals (16158)
Artificial intelligence (233)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (249)
Cancer (2011)
Cardiovascular disease (162)
Career advice (1673)
Career pathing (29)
CAR-T (140)
Cell therapy (397)
Cervical cancer (19)
Clinical research (65736)
Collaboration (768)
Compensation (463)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1977)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6336)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86214)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111690)
Executive appointments (648)
FDA (17272)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (687)
Gene editing (96)
Generative AI (18)
Gene therapy (278)
GLP-1 (685)
Government (4381)
Grass and pollen (4)
Guidances (49)
Healthcare (18808)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2713)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (311)
IPO (16485)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7901)
Liver cancer (70)
Lung cancer (293)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (268)
MASH (61)
Medical device (13327)
Medtech (13332)
Mergers & acquisitions (19406)
Metabolic disorders (632)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (1837)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2441)
Now hiring (37)
Obesity (340)
Opinion (201)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (135)
Partnered (20)
Patents (204)
Patient recruitment (96)
Peanut (46)
People (57097)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20472)
Phase II (28948)
Phase III (21578)
Pipeline (1053)
Podcasts (45)
Policy (113)
Postmarket research (2563)
Preclinical (8658)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5901)
Recruiting (65)
Regulatory (22147)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2112)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (13)
Supply chain (60)
Tariffs (11)
The Weekly (27)
United States (21262)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (88)
Last 7 days (709)
Last 30 days (2724)
Last 365 days (33507)
2025 (8193)
2024 (35219)
2023 (40077)
2022 (51175)
2021 (55710)
2020 (54083)
2019 (46539)
2018 (35023)
2017 (32113)
2016 (31481)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37709)
Australia (6165)
California (5556)
Canada (1876)
China (475)
Colorado (247)
Connecticut (256)
Delaware (128)
Europe (80863)
Florida (825)
Georgia (194)
Idaho (57)
Illinois (499)
India (24)
Indiana (291)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (8)
Maine (61)
Maryland (831)
Massachusetts (4186)
Michigan (209)
Minnesota (370)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1587)
New Mexico (28)
New York (1600)
North Carolina (921)
North Dakota (7)
Northern California (2441)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1261)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2112)
Tennessee (93)
Texas (830)
Utah (164)
Virginia (130)
Washington D.C. (57)
Washington State (513)
West Virginia (3)
Wisconsin (49)
696,311 Results for "veru inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy—Is It Enough?
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy alone but investors await more data.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
April 1, 2025
·
14 min read
BioMidwest
Veru to Present at the 2024 Jefferies Global Healthcare Conference
Veru Inc. announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present an update of Veru’s Phase 2b clinical program of enobosarm to augment fat loss and to avoid muscle loss when combined with GLP-1 drugs for weight loss at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am – 11:25 am ET.
May 22, 2024
·
10 min read
Press Releases
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
February 13, 2025
·
27 min read
Press Releases
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
13 min read
BioMidwest
Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
Veru Inc. announced that its Annual Meeting of Shareholders scheduled for today was convened and adjourned without any business being conducted due to lack of a required quorum.
June 18, 2024
·
7 min read
Press Releases
Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
February 6, 2025
·
13 min read
BioMidwest
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. announced that the Company will present two presentations at the American Diabetes Association’s 84th Scientific Sessions, taking place June 21-24, 2024, in Orlando, Florida.
June 10, 2024
·
10 min read
Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. (NASDAQ: VERU) today announced data from two late-breaker presentations at the American Diabetes Association’s 84th Scientific Sessions, which took place on June 21-24, 2024, in Orlando, Florida.
June 24, 2024
·
11 min read
Veru to Present at the GLP-1 Based Therapeutics Summit
Veru Inc. today announced that the Company has been invited to give a presentation at the GLP-1 Based Therapeutics Summit, taking place May 15-16, 2024, in Philadelphia, PA.
May 2, 2024
·
7 min read
1 of 69,632
Next
